Research Grants 2,346 show all


$26.3M
2016

$36.5M
2017

$24.2M
2018

$23.9M
2019

$579.3K
2020

Patents 431show all

  • 172
    A61K - Preparations for medical, dental, or toilet purposes
  • 128
    C07K - Peptides
  • 69
    C12N - Microorganisms or enzymes
  • 63
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 36
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 23
    Y02A - Technologies for adaptation to climate change
  • 18
    A01K - Animal husbandry
  • 16
    C12Y - Enzymes
  • 15
    C07C - Acyclic or carbocyclic compounds
  • 13
    G16B - Bioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology

Publications 3,185 show all

  • 123
    Lupus Erythematosus, Systemic/genetics
  • 98
    Lupus Erythematosus, Systemic/immunology
  • 46
    Autoantigens/immunology
  • 46
    Protein C/metabolism
  • 43
    RNA, Small Cytoplasmic
  • 42
    Transcription Factors/metabolism
  • 41
    B-Lymphocytes/immunology
  • 38
    Autoantibodies/immunology
  • 36
    Genetic Predisposition to Disease
  • 35
    Lupus Erythematosus, Systemic/drug therapy

Clinical Trials 107show all

50Phase 230Phase 37Phase 110Other

Contact Information

Oklahoma City, OK
United States